MEDAXONE

This brand name is authorized in Croatia, Estonia, Romania, South Africa, Spain.

Active ingredients

The drug MEDAXONE contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1117370, 1117381, 1117392, 1117404
ES	Centro de información online de medicamentos de la AEMPS	83553, 83554
HR	Agencija za lijekove i medicinske proizvode	HR-H-025865442
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42064001, W42064002, W42064003, W42064004, W42544001, W42544002, W42544003, W43626001, W43626002, W43626003
ZA	Health Products Regulatory Authority	A40/20.1.1/0198, A40/20.1.1/0199, A40/20.1.1/0200